Manassas County, Va., funds by Health and Human Services, Department of
Listing $2,100,908.47 in stimulus funds from Health and Human Services, Department of for Manassas
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| GEORGE MASON UNIVERSITY | $799,958 |
Trans-NIH Recovery Act Research Support Using Rewards in Justice Treatment Programs: Technology & Contingency Management: This study is designed to develop knowledge about how technology can be used in criminal justice settings to assess performance, either at the individual client level or at
This spending item is part of a $1,007,844 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
| GEORGE MASON UNIVERSITY | $394,646 | Trans-NIH Recovery Act Research Support Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcription DESCRIPTION:Human immunodeficiency virus (HIV) is the etiological agent of acquired immunodeficiency syndrome (AIDS). AIDS is characterized by CD4+ T lymphocyte depleti | National Institutes of Health | 6/23/2010 |
| GEORGE MASON UNIVERSITY | $319,214 |
Trans-NIH Recovery Act Research Support Ocular infection by human adenovirus (HAdV) species D genotypes D8, D19, D37, and D53 causes epidemic keratoconjunctivitis (EKC), manifest by acute pseudomembranous conjunctivitis, punctate and macro-epithelial erosions, and delayed onset stromal keratiti
This spending item is part of a $1,350,351 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| GEORGE MASON UNIVERSITY | $295,135 | Trans-NIH Recovery Act Research Support The long term goal of our research is to understand how the RNAi mechanism affects HIV-1 viral replication. DESCRIPTION: Human Immunodeficiency Virus type I (HIV-1) is the etiologic agent of Acquired Immunodeficiency Syndrome (AIDS). AIDS is a compl | National Institutes of Health | 6/25/2010 |
| GEORGE MASON UNIVERSITY | $200,433 | Trans-NIH Recovery Act Research Support Cancer-associated blood biomarkers exist in exceedingly low concentrations, well below the sensitivity of conventional biomarker proteomic technologies. Moreover, biomarkers are masked within complex mixtures of high-abundance proteins such as albumin and | National Institutes of Health | 9/28/2009 |
| MANASSAS, CITY OF | $70,068 |
ARRA Child Care and Development Block Grant ARRA Supplemental Discretionary Grant Award. The award represents an additional Discretionary fund obligation to the State for fiscal year 2009 for the Child Care Development Fund.
This spending item is part of a $37,891,741 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| GEORGE MASON UNIVERSITY | $10,805 | Trans-NIH Recovery Act Research Support Parent R21 Grant: Surrogate and Sentinal Technologies to Monitor Stability of Cancer Phosphoproteins The purpose of this ARRA supplement is | National Institutes of Health | 6/04/2009 |
| GEORGE MASON UNIVERSITY | $10,649 | Trans-NIH Recovery Act Research Support Parent R21 Grant: Phosphorylated Signal Pathway Proteins: A New Class of Vitreous Biomarkers for Optimizing Therapy of Wet AMD The purpose o | National Institutes of Health | 6/05/2009 |